223
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Establishment of reference interval for the tumour marker serum CYFRA 21-1 in healthy Chinese Han ethnic adults

, , , , , & show all
Pages 171-174 | Received 28 Mar 2017, Accepted 07 Jan 2018, Published online: 16 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gustav Mikkelsen, Arne Åsberg & Gunhild Garmo Hov. (2018) Are age-specific reference ranges for CYFRA 21-1 appropriate?. Scandinavian Journal of Clinical and Laboratory Investigation 78:4, pages 335-336.
Read now

Articles from other publishers (3)

昕翌 刘. (2022) Establishment of Reference Interval for the Serum Tumour Marker CA72-4 Measured by the Microarray Chemiluminescence Immunoassay System. Advances in Clinical Medicine 12:04, pages 3278-3285.
Crossref
Qian Liu, Jilong Fan, Aiguo Xu, Li Yao, Yan Li, Wenjun Wang, Wei Liang & Fumeng Yang. (2019) Distribution of serum neuron‐specific enolase and the establishment of a population reference interval in healthy adults. Journal of Clinical Laboratory Analysis 33:5.
Crossref
Bing Zhao, Miaomiao Zhang, Feng Lin, Jing Xie, Yan Liang & Zaixing Yang. (2018) Establishment of the reference interval for serum pro-gastrin-releasing peptide in healthy adults of Chinese Han ethnicity. The International Journal of Biological Markers 33:4, pages 487-491.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.